Skip to main content

BioMérieux to Distribute AdvanDx's Bacteria Dx in the US

NEW YORK (GenomeWeb News) — BioMérieux will exclusively distribute AdvanDx’s diagnostic tests in the US, the French company said Tuesday. 
 
The tests, which use in situ hybridization technology, may be used to identify Staphylococcus aureus, Candida albicans, Enterococcus faecalis and other species of bacteria in fewer than five hours, the companies said.
 
BioMérieux said the diagnostic will allow doctors to make swifter diagnoses to improve management of antibiotics, improve care, and lower costs of blood infections.
 
Financial terms of the agreement were not released.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.